{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:24:31Z","timestamp":1787927071779,"version":"build-2784847793"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010252","name":"\u015al\u0105ski Uniwersytet Medyczny w Katowicach","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The most frequent extrathyroidal Graves\u2019 disease manifestation is Graves\u2019 orbitopathy (GO). The treatment of GO is determined by its severity and activity. There is currently no reliable, impartial method for assessing it clinically or distinguishing fibrosis from active inflammatory disorders. Today, imaging methods including orbital ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) are frequently employed to show pathological abnormalities in the ocular adnexa of GO patients. In addition, a not widely accepted technique \u2013 99mTc-DTPA SPECT \u2013 has some potential to evaluate retrobulbar inflammation in GO patients. However, FDG-PET\/CT is possibly superior to other imaging modalities in detecting inflammation in GO and it may be useful in assessing disease activity in case of clinical or serological uncertainty. It might also act as an early indicator of GO development and its aggravation before irreversible tissue alterations take place and may be used in the differential diagnosis of inflammatory disorders of the orbit. However, before FDG-PET\/CT could be applied in daily clinical practice, the methodology of GO activity assessment with defined cut-off values for radionuclide concentration \u2013 standardized units of value (SUV) have to be established and validated. In addition, the limitations of this technique have to be recognized.<\/jats:p>","DOI":"10.3389\/fendo.2023.1138569","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:35:05Z","timestamp":1691080505000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET"],"prefix":"10.3389","volume":"14","author":[{"given":"Anna","family":"Ochmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Nalewajka-Ko\u0142odziejczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Chudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/1756-0500-6-353","article-title":"Orbital positron emission tomography\/computed tomography (PET\/CT) imaging findings in graves ophthalmopathy","volume":"6","author":"Garc\u00eda-Rojas","year":"2013","journal-title":"BMC Res Notes"},{"key":"B2","article-title":"Graves\u2019 Disease. 2022","volume-title":"StatPearls","author":"Pokhrel","year":"2022"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1306-5","article-title":"Epidemiology, management and outcomes of Graves\u2019 disease\u2014real life data","volume":"56","author":"Hussain","year":"2017","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01141-3","article-title":"Orbital diseases mimicking graves\u2019 orbitopathy: a long-standing challenge in differential diagnosis","volume":"43","author":"Marin\u00f2","year":"2020","journal-title":"J Endocrinol Invest."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.02.047","article-title":"Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment","volume":"142","author":"Garrity","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"249125","DOI":"10.1155\/2015\/249125","article-title":"Graves\u2019 ophthalmopathy: VISA versus EUGOGO classification, assessment, and management","volume":"2015","author":"Barrio-Barrio","year":"2015","journal-title":"J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450107","article-title":"Imaging in thyroid-associated orbitopathy","volume":"145","author":"Kahaly","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1420591","article-title":"Graves\u2019 ophthalmopathy: eye muscle involvement in patients with diplopia","volume":"142","author":"Nagy","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00973.x","article-title":"Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.20154","article-title":"Graves' ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score","volume":"33","author":"Yanik","year":"2005","journal-title":"J Clin Ultrasound"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.9.1027","article-title":"Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation","volume":"84","author":"Alp","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(11)18","article-title":"Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy","volume":"67","author":"Gon\u00e7alves","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2013.02.07","article-title":"CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy","volume":"18","author":"Fang","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.72.860.10624341","article-title":"Quantitative CT of the orbit in Graves' disease","volume":"72","author":"Ozgen","year":"1999","journal-title":"Br J Radiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2020.1817100","article-title":"Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease","volume":"41","author":"Cohen","year":"2022","journal-title":"Orbit"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31820365d5","article-title":"Densities of orbital fat and extraocular muscles in graves orbitopathy patients and controls","volume":"27","author":"Regensburg","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1144-y","article-title":"Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI","volume":"30","author":"Meller","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.11.009","article-title":"Neuroimaging of graves\u2019 orbitopathy","volume":"26","author":"M\u00fcller-Forell","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-002-0930-8","article-title":"A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy","volume":"45","author":"Aydin","year":"2003","journal-title":"Neuroradiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3881\/j.issn.1000-503X.2012.05.005","article-title":"Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves\u2019 ophthalmopathy with upper-lid retraction","volume":"34","author":"Chen","year":"2012","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao."},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1258\/ar.2011.110431","article-title":"Evaluation of rectus extraocular muscles using dynamic contrast enhanced MR imaging in patients with Graves\u2019 ophthalmopathy for assessment of disease activity","volume":"53","author":"Jiang","year":"2012","journal-title":"Acta Radiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/02841851211034042","article-title":"Evaluation of extraocular muscles in patients with thyroid associated ophthalmopathy using apparent diffusion coefficient measured by magnetic resonance imaging before and after radiation therapy","volume":"63","author":"Yu","year":"2022","journal-title":"Acta Radiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12902-019-0340-0","article-title":"Efficacy of 99mTc-DTPA SPECT\/CT in diagnosing Orbitopathy in graves' disease","volume":"19","author":"Szumowski","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200212000-00010","article-title":"SPECT using 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy: a comparison with the results from MRI","volume":"23","author":"Galuska","year":"2002","journal-title":"Nucl Med Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200505000-00003","article-title":"Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores","volume":"26","author":"Galuska","year":"2005","journal-title":"Nucl Med Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32835c19f0","article-title":"The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy","volume":"34","author":"Szabados","year":"2013","journal-title":"Nucl Med Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"529187","DOI":"10.1155\/2013\/529187","article-title":"18-Fluorodeoxyglucose uptake by positron emission tomography in extraocular muscles of patients with and without graves\u2019 ophthalmology","volume":"2013","author":"Garc\u00eda-Rojas","year":"2013","journal-title":"J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100563","article-title":"FDG-PET as a \u201cmetabolic biopsy\u201d tool in thoracic lesions with indeterminate biopsy","volume":"28","author":"Hain","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-001-0736-7","article-title":"FDG-PET as a \u201cmetabolic biopsy\u201d tool in non-lung lesions with indeterminate biopsy","volume":"29","author":"Beggs","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2484-x","article-title":"SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions","volume":"40","author":"Kwee","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.419","article-title":"Images in thyroidology* Imaging of inflammation in graves\u2019 Ophthalmopathy by positron emission tomography\/computed tomography","volume":"16","author":"Kuo","year":"2006","journal-title":"Thyroid"},{"key":"B33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/MNM.0b013e3283299a52","article-title":"[18F]Fluorodeoxyglucose-PET\/CT differentiation between physiological and pathological accumulations in head and neck","volume":"30","author":"Nakamura","year":"2009","journal-title":"Nucl Med Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000737","article-title":"Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves\u2019 disease for evaluation of active inflammation","volume":"38","author":"Uslu-Be\u015fli","year":"2017","journal-title":"Nucl Med Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1957943","article-title":"F-18 fluorodeoxyglucose PET\/CT as a diagnostic tool in orbital inflammatory disorders","volume":"30","author":"Elourimi","year":"2022","journal-title":"OcularImmunol Inflammation"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05339-1","article-title":"18 F-FDG-PET\/MRI in patients with Graves\u2019 orbitopathy","volume":"259","author":"Weber","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13550-019-0530-9","article-title":"Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease","volume":"9","author":"Laban","year":"2019","journal-title":"EJNMMI Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04599-8","article-title":"Zirconium-89 labelled rituximab PET-CT imaging of Graves\u2019 orbitopathy","volume":"47","author":"de Keizer","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31821a2618","article-title":"Ga-68-DOTA-NOC PET\/CT reveals active graves\u2019 Orbitopathy in a single extraorbital muscle","volume":"36","author":"Pichler","year":"2011","journal-title":"Clin Nucl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020790","article-title":"Somatostatin receptor genes are expressed in lymphocytes from retroorbital tissues in Graves\u2019 disease","volume":"87","author":"Pasquali","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1138569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:35:13Z","timestamp":1691080513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1138569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":40,"alternative-id":["10.3389\/fendo.2023.1138569"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1138569","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"article-number":"1138569"}}